Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

solvent

solvent is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 19
Pipeline programs 84
News articles 0
Drug details — solvent
Class
—
Route
—
Patents
19
Programs
84
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

solvent is an FDA-listed pharmaceutical active ingredient.

Key facts

INN solvent

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. 0600-PG-PSC-218 Phase 3 · Anaxis Pharma · Allergic rhinoconjunctivitis with or without controlled asth
  3. 060018-PG-PSC-217 Phase 3 · Anaxis Pharma · Allergic rhinoconjunctivitis with or without asthma due to c
  4. 071102 Phase 3 · Baxalta Innovations · Hereditary severe von Willebrand Disease in children
  5. 111-302 Phase 3 · BioMarin Pharmaceutical Australia · Achondroplasia
  6. 111-303 Phase 3 · BioMarin Pharmaceutical Australia · Hypochondroplasia
  7. 111-308 Phase 3 · BioMarin Pharmaceutical Australia · Hypochondroplasia
  8. 2019/2894 Phase 3 · George Institute for · Patients with High Risk Neuroblastoma

Related patents

Browse patents

  1. US 12318376

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11964003

    Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11957736

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11576951

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11452674

    Non-solvent dental adhesive composition

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11253504

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10485850

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10420720

    Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

    Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10398686

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9913909

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9744163

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9675544

    Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9649364

    Methods for producing stable therapeutic formulations in aprotic polar solvents

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9592227

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9446036

    Compositions of a polyorthoester and an aprotic solvent

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8835505

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8829054

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8314122

    Using of organic solvents in wet granulation of moxifloxacin

    Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7153838

    Pharmacologically acceptable solvent vehicles

    Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is solvent?

solvent is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.